Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
U.S. clears updated COVID boosters targeting newest variants
10:10am, Wednesday, 31'st Aug 2022
The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicron strain. Shots could begin within days.
FDA Authorizes Moderna and Pfizer Omicron Booster Shots
10:05am, Wednesday, 31'st Aug 2022
The move comes just as the country braces for a potential fall surge in Covid-19 infections.
Could Pfizer Beat Moderna in This New Billion-Dollar Market?
06:00am, Wednesday, 31'st Aug 2022
Pfizer and Moderna are both tackling a common respiratory virus.
Should Pfizer Investors Be Worried About Moderna's Lawsuits?
05:52am, Wednesday, 31'st Aug 2022
Pfizer and BioNTech plan to aggressively defend against Moderna's claims of patent infringement.
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
02:17pm, Tuesday, 30'th Aug 2022
Moderna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent booster vaccine mRNA-1273.214 in adults, making it the first bivalent COVID-19 vaccine approved for use in
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
06:00am, Tuesday, 30'th Aug 2022
They still might offer solid long-term opportunities for investors.
Is Moderna Stock A Buy As FDA Mulls Its Updated Covid Booster Shot?
02:28pm, Monday, 29'th Aug 2022
Is Moderna stock a buy after asking the FDA to sign off on its BA.4- and BA.5-tailored Covid booster? Is MRNA stock a buy now?
Moderna (MRNA) Sues Pfizer and BioNTech Over COVID Jab
12:47pm, Monday, 29'th Aug 2022
Moderna (MRNA) sues Pfizer and BioNTech, alleging that Comirnaty infringes on patents that Moderna filed from 2010 to 2016 related to its mRNA technology.
Moderna Suing Pfizer Isn't a ‘Big Deal' Yet | TheStreet
09:08am, Monday, 29'th Aug 2022
Moderna is planning to sue Pfizer for patent infringement, but it's not a big deal just yet. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video ACTION ALERTS PLUS | https
The 8 Most Profitable U.S. Companies Practically Print Money
08:00am, Monday, 29'th Aug 2022
Imagine companies three times as profitable as the S&P 500 — putting them in a good position to handle whatever comes next. The post The 8 Most Profitable U.S. Companies Practically Print Money appe
Swiss regulator grants temporary authorization for Moderna bivalent COVID booster for adults age 18 and older
06:25am, Monday, 29'th Aug 2022
Moderna Inc. MRNA, -3.77% said Monday the Swiss regulator has granted temporary authorization to its bivalent omicron-targeting COVID booster for use in adults aged 18 and older. "Spikevax Bivalent Or
Better COVID Booster Stock: Moderna vs. Pfizer
06:00am, Monday, 29'th Aug 2022
These vaccine leaders are set to target the latest coronavirus variant.
Could This Move by Moderna Cost Pfizer Billions?
10:00am, Sunday, 28'th Aug 2022 The Motley Fool
Moderna's complaint is focused on two critical innovations.
Could This Move by Moderna Cost Pfizer Billions?
06:00am, Sunday, 28'th Aug 2022
Moderna's complaint is focused on two critical innovations.
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
01:20pm, Saturday, 27'th Aug 2022 MarketWatch
Moderna Inc. on Friday filed lawsuits against Pfizer Inc. and German partner BioNTech SE, alleging the pair infringed patents relating to its mRNA platform, a key technology behind all of their COVID
